Dorosan (Aerosol) Instructions for Use
Marketing Authorization Holder
Rottapharm S.r.l. (Italy)
ATC Code
M02AA15 (Diclofenac)
Active Substance
Diclofenac (Rec.INN registered by WHO)
Dosage Form
| Dorosan | External use aerosol 1%: 50 ml canisters |
Dosage Form, Packaging, and Composition
| Aerosol for external use 1% | 1 ml |
| Diclofenac sodium | 10 mg |
50 ml – aluminum aerosol cans (1) – cardboard packs.
Clinical-Pharmacological Group
NSAIDs for external use
Pharmacotherapeutic Group
NSAID
Pharmacological Action
The active component Diclofenac is a non-steroidal anti-inflammatory drug with pronounced analgesic and anti-inflammatory properties.
By non-selectively inhibiting cyclooxygenase types 1 and 2, it disrupts the metabolism of arachidonic acid and the synthesis of prostaglandins, which are the main link in the development of inflammation.
Dorosan is used to eliminate pain and reduce swelling associated with the inflammatory process.
Indications
- Post-traumatic inflammation of soft tissues and joints, for example, due to sprains, strains, and contusions;
- Rheumatic diseases of soft tissues (tenosynovitis, bursitis, damage to periarticular tissues);
- Pain and swelling associated with diseases of muscles and joints (rheumatoid arthritis, osteoarthritis, radiculitis, lumbago, sciatica).
ICD codes
| ICD-10 code | Indication |
| M05 | Seropositive rheumatoid arthritis |
| M15 | Polyosteoarthritis |
| M25.5 | Pain in joint |
| M54.1 | Radiculopathy |
| M54.3 | Sciatica |
| M54.4 | Lumbago with sciatica |
| M65 | Synovitis and tenosynovitis |
| M70 | Soft tissue disorders related to use, overuse, and pressure |
| M71 | Other bursopathies |
| M79 | Other soft tissue disorders, not elsewhere classified |
| M79.1 | Myalgia |
| T14.3 | Dislocation, sprain and strain of joint and ligament of unspecified body region |
| ICD-11 code | Indication |
| 8B93.Z | Radiculopathy, unspecified |
| 8E4A.1 | Paraneoplastic or autoimmune diseases of the peripheral or autonomic nervous system |
| FA05 | Polyosteoarthritis |
| FA20.0 | Seropositive rheumatoid arthritis |
| FB40.Z | Tenosynovitis, unspecified |
| FB50.1 | Bursitis associated with use, overuse or pressure |
| FB50.Z | Bursitis, unspecified |
| FB56 | Specified soft tissue diseases, not elsewhere classified |
| FB56.2 | Myalgia |
| ME82 | Pain in joint |
| ME84.20 | Lumbago with sciatica |
| ME84.3 | Sciatica |
| ND56.3 | Dislocation, sprain or strain of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Remove the protective cap from the container, apply the foam to the painful area by pressing the special button, and close the container with the cap.
Depending on the size of the affected area, the foam is applied 3-4 times/day to the painful areas by pressing the special button for 1-2 seconds, and light massage promotes the absorption of the drug.
The duration of treatment depends on the indications and the observed effect. After 2 weeks of using the drug, a doctor should be consulted.
Adverse Reactions
Local reactions eczema, photosensitivity, contact dermatitis (itching, redness, swelling of the treated skin area, papules, vesicles, peeling).
Systemic reactions generalized skin rash, allergic reactions (urticaria, angioedema, bronchospastic reactions), photosensitivity.
Contraindications
- “aspirin” asthma;
- Pregnancy (III trimester);
- Lactation period;
- Children under 12 years of age;
- Impaired skin integrity;
- Hypersensitivity to diclofenac, or other components of the drug, acetylsalicylic acid or other NSAIDs.
With caution hepatic porphyria (exacerbation), erosive and ulcerative lesions of the gastrointestinal tract, severe impairment of liver and kidney function, chronic heart failure, bronchial asthma, elderly age, pregnancy I and II trimester.
Use in Pregnancy and Lactation
The drug should not be used in the III trimester of pregnancy. Use in the I and II trimesters is possible only after consultation with a doctor.
Use in Hepatic Impairment
With caution hepatic porphyria (exacerbation), severe liver dysfunction.
Use in Renal Impairment
With caution renal impairment.
Pediatric Use
Contraindicated in children under 12 years of age.
Geriatric Use
Use with caution in the elderly.
Special Precautions
Dorosan should be applied only to intact skin, avoiding contact with open wounds. After application, an occlusive dressing should not be applied. Avoid contact of the drug with eyes and mucous membranes.
The container is under pressure, do not puncture or burn the container even after use, do not expose to direct sunlight, do not freeze, do not heat above 50°C (122°F).
Overdose
Extremely low systemic absorption of the active components of the drug with external use makes overdose practically impossible.
Drug Interactions
Dorosan may enhance the effect of drugs that cause photosensitivity. Clinically significant interaction with other drugs has not been described.
Storage Conditions
Store at a temperature not exceeding 25°C (77°F), in places inaccessible to children.
Shelf Life
Shelf life – 3 years.
Dispensing Status
The drug is dispensed by prescription.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Ingavirin capsules 90mg, 10pcs
Daivobet, ointment, 30g
Picamilon pills 50mg, 60pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Phenibut-Vertex pills 250mg, 20pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Fenotropil pills 100mg, 60pcs
Belosalic, lotion solution for external use spray 100ml
Kagocel pills 12mg, 30pcs
Noopept, pills 10mg, 50pcs 